Open Label Phase II Trial of Bendamustine Hydrochloride (HCL) in Women With Advanced Ovarian Cancer
Phase of Trial: Phase II
Latest Information Update: 01 Feb 2016
At a glance
- Drugs Bendamustine (Primary)
- Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 28 Nov 2012 Primary endpoints added as reported by ClinicalTrials.gov.
- 01 Oct 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.